Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian API Drug Maker Shasun To Expand Japanese Market

This article was originally published in PharmAsia News

Executive Summary

Indian active pharmaceutical ingredient maker Shasun Chemicals and Drugs plans to expand into the Japanese market, announced by Shasun VP Michel Spagnol at a March 3 Tokyo briefing. The company established Japanese subsidiary Shasun Japan last year, and has set sales goal of $7 million for 2009. Shasun looks to expand into the clinical research business and API and drug medium production in Japan. The company also plans to collaborate with Japanese domestic drug makers. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts